Stable monohydrate of df2755a and process for its preparation
AssigneeDompé Farmaceutici S.P.A.
InventorsGianluca BIANCHINI, Andrea ARAMINI, Marcello ALLEGRETTI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a stable monohydrate of compound DF2755A, to a process for its manufacture, to its pharmaceutical compositions and medical uses. The monohydrate of compound DF2755A of the present invention is physically, chemically and optically stable, thus particularly advantageous for pharmaceutical applications.
Claims15
Crystalline monohydrate sodium (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoate characterized by an X-ray diffraction pattern (XRPD) with peaks at 7.9, 18.3, 19.8, 23.8 and 25.5° 2-theta±0.2 degrees 2-theta as measured by X-ray diffractometry by irradiation with Cu Kα X-rays.
A process for the preparation of crystalline monohydrate sodium (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoate comprising:
- i) providing anhydrous sodium (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoate;
- and
- ii) exposing it to an atmosphere having a Relative Humidity (R.H.) higher than 60% and lower than 80% by weight, at a temperature from 25° C. to 40° C. and at atmospheric pressure, thus providing crystalline monohydrate sodium (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoate.
A process for the preparation of anhydrous sodium (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoate comprising:
- providing a solution of (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoic acid in a solvent selected among ethyl acetate, isobutyl acetate, propyl acetate and admixtures thereof, in which the concentration of the acid in the solution is from 0.08 to 0.12 kg/I,
- adding to the solution a sodium base in a molar ratio compared to the acid from 0.9:1 to 0.95:1, thus providing an admixture,
- adding to the admixture an anti-solvent selected among toluene, m-xylene, p-xylene and admixtures thereof, the anti-solvent being in a volumetric ratio compared to the solvent from 0.4:1 to 0.6:1, thus precipitating anhydrous sodium (2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl] amino} phenyl) propanoate.
Dependencies are inferred from the claim text.